104 related articles for article (PubMed ID: 16128227)
1. Pulmonary involvement in systemic sclerosis due to therapy and as a complication.
Chiappini F; Zoli A; Maugeri L
Monaldi Arch Chest Dis; 2005 Jun; 63(2):111-3. PubMed ID: 16128227
[TBL] [Abstract][Full Text] [Related]
2. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature.
Derk CT; Jimenez SA
J Rheumatol; 2003 Jul; 30(7):1616-20. PubMed ID: 12858467
[TBL] [Abstract][Full Text] [Related]
3. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine.
Boehler A; Vogt P; Speich R; Weder W; Russi EW
Eur Respir J; 1996 Jun; 9(6):1317-9. PubMed ID: 8804954
[TBL] [Abstract][Full Text] [Related]
4. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis.
Shapiro M; Jimenez S; Werth VP
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):297-9. PubMed ID: 10642693
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide therapy for scleroderma.
Akesson A
Curr Opin Rheumatol; 1998 Nov; 10(6):579-83. PubMed ID: 9812219
[TBL] [Abstract][Full Text] [Related]
6. Transient acantholytic dermatosis (Grover's disease) in a patient with progressive systemic sclerosis treated with D-penicillamine.
Zvulunov A; Grunwald MH; Avinoach I; Halevy S
Int J Dermatol; 1997 Jun; 36(6):476-7. PubMed ID: 9248901
[No Abstract] [Full Text] [Related]
7. [Pulmonary involvement in progressive systemic sclerosis].
Grisanti M; Vicencio M
Rev Med Chil; 1986 Oct; 114(10):1002-5. PubMed ID: 3575934
[No Abstract] [Full Text] [Related]
8. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.
Katayama Y; Kohriyama K; Matsui T
J Rheumatol; 1999 Nov; 26(11):2493-5. PubMed ID: 10555917
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients.
Koh ET; Lee P; Gladman DD; Abu-Shakra M
Br J Rheumatol; 1996 Oct; 35(10):989-93. PubMed ID: 8883438
[TBL] [Abstract][Full Text] [Related]
10. Postural changes, dysphagia, and systemic sclerosis.
Barrera P; den Broeder AA; van den Hoogen FH; van Engelen BG; van de Putte LB
Ann Rheum Dis; 1998 Jun; 57(6):331-8. PubMed ID: 9771206
[No Abstract] [Full Text] [Related]
11. [A case of myasthenia gravis caused by D-penicillamine therapy].
Susa S; Akiba J; Kurimura M; Kurita K; Daimon M; Manaka H; Yamatani K; Kato T
Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2513-5. PubMed ID: 9922674
[No Abstract] [Full Text] [Related]
12. Asymptomatic annular plaques on the neck.
Chabra IS; Grandinetti LM
Cutis; 2014 Oct; 94(4):E1-3. PubMed ID: 25372260
[No Abstract] [Full Text] [Related]
13. Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.
Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K
Ann Rheum Dis; 2003 Oct; 62(10):1019-20. PubMed ID: 12972489
[No Abstract] [Full Text] [Related]
14. A case study and national database report of progressive systemic sclerosis and associated conditions.
Phillips D; Phillips B; Mannino D
J Womens Health; 1998 Nov; 7(9):1099-104. PubMed ID: 9861587
[TBL] [Abstract][Full Text] [Related]
15. Organizing diffuse alveolar damage associated with progressive systemic sclerosis.
Muir TE; Tazelaar HD; Colby TV; Myers JL
Mayo Clin Proc; 1997 Jul; 72(7):639-42. PubMed ID: 9212765
[TBL] [Abstract][Full Text] [Related]
16. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
[TBL] [Abstract][Full Text] [Related]
17. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.
Poulas K; Koutsouraki E; Kordas G; Kokla A; Tzartos SJ
J Neuroimmunol; 2012 Sep; 250(1-2):94-8. PubMed ID: 22683336
[TBL] [Abstract][Full Text] [Related]
18. Progressive systemic sclerosis complicated with immune thrombocytopenia during D-penicillamine therapy.
Natsuda H; Matsui Y; Sakauchi M; Kato S; Takemura H; Suzuki H; Kono I; Yamane K; Kashiwagi H
Intern Med; 1992 Feb; 31(2):244-5. PubMed ID: 1600273
[TBL] [Abstract][Full Text] [Related]
19. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
[TBL] [Abstract][Full Text] [Related]
20. Penicillamine therapy in systemic sclerosis.
Jayson MI; Lovell C; Black CM; Wilson RS
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):82-8. PubMed ID: 122683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
